Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share Attributable to Common Stockholders - Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share (Details)

v3.22.1
Net Loss Per Share Attributable to Common Stockholders - Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share (Details) - shares
shares in Thousands
3 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Class A Common Stock    
Total 42,954 339,609
Class A Common Stock | Convertible preferred stock    
Total 0 278,940
Class A Common Stock | Unvested RSUs    
Total 27,271 36,184
Class A Common Stock | Outstanding stock options    
Total 13,786 22,205
Class A Common Stock | Shares subject to repurchase from RSAs and early exercised stock options    
Total 862 2,280
Class A Common Stock | Shares issuable under ESPP    
Total 1,035 0
Class B Common Stock    
Total 0 0
Class B Common Stock | Convertible preferred stock    
Total 0 0
Class B Common Stock | Unvested RSUs    
Total 0 0
Class B Common Stock | Outstanding stock options    
Total 0 0
Class B Common Stock | Shares subject to repurchase from RSAs and early exercised stock options    
Total 0 0
Class B Common Stock | Shares issuable under ESPP    
Total 0 0